Entero Therapeutics, Inc. (formerly First Wave Biopharma, Inc.) is a clinical-stage biopharmaceutical company focused on non-systemic therapies for gastrointestinal diseases. Its primary candidate is Adrulipase, a recombinant lipase enzyme derived from Yarrowia lipolytica, targeting exocrine pancreatic insufficiency in cystic fibrosis and chronic pancreatitis patients. Prior programs including Latiglutenase, Capeserod, and Niclosamide have been discontinued. The company completed and subsequently rescinded a merger with ImmunogenX, Inc.
expected 2026-12-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-01 | 2024-12-31 | 0001410578-25-000618 | EDGAR | 84K words |
| 2024-03-29 | 2023-12-31 | 0001410578-24-000364 | EDGAR | 96K words |
| 2023-03-20 | 2022-12-31 | 0001410578-23-000299 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001140361-22-012347 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001654954-21-003659 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001654954-20-003530 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001654954-19-003863 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001654954-18-002715 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001654954-17-002925 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-21 | 2026-06-30 | 0001104659-26-099751 | EDGAR | 31K words |
| 2025-11-19 | 2025-09-30 | 0001104659-25-114181 | EDGAR | 34K words |
| 2025-08-14 | 2025-06-30 | 0001410578-25-001790 | EDGAR | 30K words |
| 2025-05-15 | 2025-03-31 | 0001410578-25-001311 | EDGAR | 27K words |
| 2024-11-13 | 2024-09-30 | 0001410578-24-001914 | EDGAR | 31K words |
| 2024-10-21 | 2024-06-30 | 0001410578-24-001685 | EDGAR | 30K words |
| 2024-05-14 | 2024-03-31 | 0001410578-24-000826 | EDGAR | 24K words |
| 2023-11-13 | 2023-09-30 | 0001410578-23-002410 | EDGAR | 26K words |
| 2023-08-14 | 2023-06-30 | 0001410578-23-001882 | EDGAR | 19K words |
| 2023-05-12 | 2023-03-31 | 0001410578-23-001056 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001410578-22-003295 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001410578-22-002519 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-11 | 0001104659-26-107100 | EDGAR | 6K words |
| 2026-07-23 | 0001104659-26-086250 | EDGAR | 14K words |
| 2026-01-07 | 0001104659-26-001755 | EDGAR | 3K words |
| 2025-12-23 | 0001104659-25-124213 | EDGAR | 3K words |
| 2025-12-04 | 0001104659-25-118524 | EDGAR | 1K words |
| 2025-11-06 | 0001104659-25-107715 | EDGAR | 1K words |
| 2025-10-31 | 0001104659-25-104917 | EDGAR | 1K words |
| 2025-10-22 | 0001104659-25-101519 | EDGAR | 20K words |
| 2025-10-06 | 0001104659-25-097138 | EDGAR | 1K words |
| 2025-09-12 | 0001104659-25-089562 | EDGAR | 2K words |
323 total filings indexed. 292 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001604191 |
| Ticker | GRDX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.enterothera.com |
| Listed | 2016-10-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/GRDX (~200 tokens, structured JSON with cryptographic provenance)